巴西社区获得性呼吸道感染背景下的抗菌药物耐药性国家数据:抗生素敏感性、当地及国际抗生素处方指南、药物可及性与临床结局之间的关联
该综述梳理了巴西抗菌药物耐药性(AMR)现状、国家行动计划、抗生素使用与处方情况,以及社区获得性呼吸道感染(CA-RTI)关键病原体肺炎链球菌和流感嗜血杆菌的药敏数据可得性。文中还回顾了当地常用的国家和国际CA-RTI抗生素处方指南及抗生素可及性,指出巴西抗生素消费量高,但禁止非处方销售后消费量下降。作者认为需增加本地药敏检测,并以最新监测数据制定更具本地相关性的指南,以促进合理处方和改善临床结局。
要点
- 巴西已于2018年建立国家抗菌药物耐药性行动计划。
- 巴西抗生素消费量高,但禁止非处方销售后消费量下降。
- 需增加本地药敏检测,SOAR巴西研究将提供CA-RTI病原体有用数据。
核心结论
- 巴西已采取国家抗菌药物耐药性行动计划(2018年建立)等举措应对AMR。
- 巴西抗生素消费量高,但禁止非处方销售抗生素后消费量下降。
- 需增加本地抗生素药敏检测,SOAR巴西研究将为CA-RTI病原体提供有用数据。
- 采用更标准化且包容的方法、利用巴西社区获得性感染分离株的最新监测数据制定本地指南,可使指南对临床医生更具本地相关性。
- 此举可促进更高水平的适当抗生素处方和依从性,从而可能限制AMR发展并改善患者临床结局。
研究设计与样本
- 综述巴西应对AMR的国家举措、抗生素使用与处方情况,以及药敏数据(尤其肺炎链球菌和流感嗜血杆菌)的可得性。
- 回顾当地常用的国家和国际CA-RTI抗生素处方指南(社区获得性肺炎、急性中耳炎和急性细菌性鼻窦炎)及当地抗生素可及性。
主要发现
- 巴西抗生素消费量高,但禁止非处方销售抗生素后消费量下降。
- 巴西已于2018年建立国家抗菌药物耐药性行动计划。
- 需增加本地抗生素药敏检测,SOAR巴西研究将提供CA-RTI病原体有用数据。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antimicrobial resistance (AMR) is one of the biggest threats to global public health. Selection of resistant bacteria is driven by inappropriate use of antibiotics, amongst other factors. COVID-19 may have exacerbated AMR due to unnecessary antibiotic prescribing. Country-level knowledge is needed to understand options for action. OBJECTIVES: To review the situation with respect to AMR in Brazil and initiatives addressing it. Identifying areas where more information is required will provide a call to action to minimize any further rises in AMR within Brazil and to improve patient outcomes. METHODS: National initiatives to address AMR, antibiotic use and prescribing in Brazil, and availability of susceptibility data, particularly for the key community-acquired respiratory tract infections (CA-RTI) pathogens Streptococcus pneumoniae and Haemophilus influenzae, were identified. National and international antibiotic prescribing guidelines for CA-RTIs (community-acquired pneumonia, acute otitis media and acute bacterial rhinosinusitis) commonly used locally were also reviewed, along with local antibiotic availability. CONCLUSIONS: In Brazil there have been some initiatives addressing AMR such as the National Action Plan for AMR, established in 2018. Antibiotic consumption in Brazil is high but a ban on over-the-counter sales of antibiotics has led to a decrease in consumption. Local antibiotic susceptibility testing needs to be increased and the Survey of Antibiotic Resistance (SOAR) study in Brazil will provide useful data for pathogens causing CA-RTIs. A more standardized inclusive approach in developing local guidelines, using up-to-date surveillance data of isolates from community-acquired infections in Brazil, could make guideline use more locally relevant for clinicians. This would pave the way for a higher level of appropriate antibiotic prescribing and improved adherence. This would, in turn, potentially limit AMR development and improve clinical outcomes for patients.
引用
- Torumkuney D, Nijhara P, Beltrame CO, et al. Country data on AMR in Brazil in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome. J Antimicrob Chemother. 2022. PMID: 36065730. doi:10.1093/jac/dkac215
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。